Literature DB >> 33637098

Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma.

Ping Zhou1, Lei Xiao2, Xiaonan Xu3.   

Abstract

BACKGROUND: As a tumor-accelerating transcriptional factor, E2F transcription factor 7 (E2F7) was up-regulated in many forms of cancers. Nevertheless, little has been reported about the impacts of E2F7 on oral squamous cell carcinoma (OSCC). Here, we aimed to probe whether E2F7 had influences on OSCC and its potential mechanism.
METHODS: The expression of E2F7 in OSCC tissues was analyzed using the data acquired from TCGA and ONCOMINE databases. E2F7 prognostic value in OSCC patients was analyzed utilizing TCGA database. The expression of E2F7 in OSCC cell lines was detected by qRT-PCR. Gain-and loss-function of E2F7 assays in TCA-83 and CAL27 cells were performed respectively to inquire the function of E2F7. Western blotting was applied to test the alternations of EMT-related markers.
RESULTS: In OSCC tissues, E2F7 was highly expressed. Besides, high expression of E2F7 predicted worse prognosis in OSCC patients. Moreover, E2F7 was over-expressed in TCA-83, HSC-4 and CAL27 (all OSCC cell lines) cells relative to that in HNOK (a normal cell line) cells. Gain-and loss-function assays displayed that deficiency of E2F7 suppresses CAL27 cell growth, migration, invasion and E2F7 high-expression resulted in inverse outcomes in TCA-83 cells. Finally, we found that silencing of E2F7 facilitated E-cadherin protein expression level and reduced N-cadherin, Vimentin and Snail protein levels in CAL27 cells, whilst E2F7 high-expression exhibited the opposite effects in TCA-83 cells.
CONCLUSIONS: These outcomes indicated that E2F7 performs a carcinogenic role in OSCC, which provides a theoretical basis for the therapeutic strategies of OSCC.

Entities:  

Keywords:  E2F transcription factor 7; Epithelial–mesenchymal transition; Growth; Invasion; Migration; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33637098      PMCID: PMC7908640          DOI: 10.1186/s13005-021-00258-2

Source DB:  PubMed          Journal:  Head Face Med        ISSN: 1746-160X            Impact factor:   2.151


  34 in total

1.  Expression of E-cadherin and vimentin in oral squamous cell carcinoma.

Authors:  Jingping Zhou; Detao Tao; Qing Xu; Zhenlin Gao; Daofang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.

Authors:  Chai Phei Gan; Kin Kit Sam; Pei San Yee; Nur Syafinaz Zainal; Bernard Kok Bang Lee; Zainal Ariff Abdul Rahman; Vyomesh Patel; Aik Choon Tan; Rosnah Binti Zain; Sok Ching Cheong
Journal:  Cell Oncol (Dordr)       Date:  2019-04-04       Impact factor: 6.730

3.  E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.

Authors:  Yuncheng Li; Erich M Sturgis; Lijun Zhu; Xiaoli Cao; Qingyi Wei; Hua Zhang; Guojun Li
Journal:  Mol Carcinog       Date:  2017-01-02       Impact factor: 4.784

4.  AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.

Authors:  Hou Dawei; Dong Honggang; Wang Qian
Journal:  Biochem Biophys Res Commun       Date:  2018-11-16       Impact factor: 3.575

5.  Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma.

Authors:  Xu Zhi; Katarzyna Lamperska; Paweł Golusinski; Nicholas J Schork; Lukasz Luczewski; Wojciech Golusinski; Michal M Masternak
Journal:  Growth Horm IGF Res       Date:  2014-04-22       Impact factor: 2.372

6.  E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation.

Authors:  Liliana Endo-Munoz; Alison Dahler; Ngari Teakle; Danny Rickwood; Mehlika Hazar-Rethinam; Ibtissam Abdul-Jabbar; Scott Sommerville; Ian Dickinson; Pritinder Kaur; Sophie Paquet-Fifield; Nicholas Saunders
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

7.  Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.

Authors:  Zongcheng Yang; Xiuming Liang; Yue Fu; Yingjiao Liu; Lixin Zheng; Fen Liu; Tongyu Li; Xiaolin Yin; Xu Qiao; Xin Xu
Journal:  EBioMedicine       Date:  2019-08-10       Impact factor: 8.143

8.  E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer.

Authors:  Shanshan Xiang; Zheng Wang; Yuanyuan Ye; Fei Zhang; Huaifeng Li; Yang Yang; Huijie Miao; Haibin Liang; Yijian Zhang; Lin Jiang; Yunping Hu; Lei Zheng; Xiyong Liu; Yingbin Liu
Journal:  Oncogene       Date:  2018-09-25       Impact factor: 8.756

9.  Reciprocal expression of Slug and Snail in human oral cancer cells.

Authors:  Ryosuke Nakamura; Hiroki Ishii; Kaori Endo; Asami Hotta; Eiji Fujii; Keiji Miyazawa; Masao Saitoh
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

10.  Nicotinic Acetylcholine Receptor Subunit Alpha-5 Promotes Radioresistance via Recruiting E2F Activity in Oral Squamous Cell Carcinoma.

Authors:  Che-Hsuan Lin; Hsun-Hua Lee; Chia-Hao Kuei; Hui-Yu Lin; Long-Sheng Lu; Fei-Peng Lee; Jungshan Chang; Jia-Yi Wang; Kai-Cheng Hsu; Yuan-Feng Lin
Journal:  J Clin Med       Date:  2019-09-12       Impact factor: 4.241

View more
  1 in total

1.  Krüppel-like factor 5 promotes the progression of oral squamous cell carcinoma via the baculoviral IAP repeat containing 5 gene.

Authors:  Yuehua Li; Wen Shi; Yajun Shen; Li Xu; Zhigang Cai; Xiaofeng Shan
Journal:  Ann Transl Med       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.